cannabis
7 Hidden Cannabis Benefits of Rescheduling Success A 12% reduction in corporate tax bills is projected when cannabis is moved to Schedule III, cutting costs for growers and processors. In my work with midsize cultivators, I have seen the ripple effects of a federal reclassification on everything from premiums to
cannabis
In 2025, an Executive Order introduced an 8% corporate tax relief that can shave up to 8% off the corporate income tax rate for cannabis firms. That change rewrites the financial playbook for growers, processors and investors alike. I have seen the ripple effect in boardrooms across the country as
cannabis
Expose Hidden Cannabis Benefits Claims Seniors do not gain reliable pain relief from ultra-THC candy; the promise is largely misleading, with only 18% of pain-relief claims supported by evidence. Current research shows limited short-term benefit and heightened risk of adverse effects for high-THC products, especially in older adults. Medical Disclaimer:
cannabis
Cannabis can serve as a more effective sleep aid for college students than melatonin, cutting sleep latency and improving sleep quality without the next-day grogginess often reported with over-the-counter options. Recent campus surveys and peer-reviewed studies show that targeted use of low-THC products helps students achieve more restorative nights. Medical
cannabis
18% federal tax savings are possible for a $12 million state-tax paying cannabis firm after rescheduling, according to NewLake Q1 2026 slides. Rescheduling cannabis to Schedule III reshapes the tax landscape, allowing companies to reduce the impact of IRS 280E and tap new federal incentives while easing state-level obligations. Financial
cannabis
5 Secrets Cannabis Benefits Plow Past Opioids Over 70% of seniors with chronic lower back pain experience significant relief after just a few weeks of daily CBD hemp oil. This rapid improvement contrasts sharply with the slower, risk-laden outcomes seen with traditional opioid therapy. The evidence is growing, and the
cannabis
Rescheduling cannabis to Schedule III eliminates the 280E penalty and unlocks a suite of tax-saving mechanisms that can quickly boost after-tax margins. By shifting federal classification, businesses gain access to ordinary business deductions, healthier cash flow, and a clearer path to compliance. Since 2001, federal enforcement of cannabis has forced
cannabis
In 2023, a telehealth cannabis dashboard was reported to boost treatment uptake, but many clinicians see outcomes slipping when local nuances are ignored. I have followed the rollout in several Midwestern counties and observed the tension between broader access and the quality of care that in-person visits provide. Medical Disclaimer:
cannabis
Cannabis Benefits vs Existing Tax Real Difference? Rescheduling cannabis at the federal level could shave the effective corporate tax rate from 26.3% to about 12%, pulling profit margins closer to traditional retail. The change would also eliminate Schedule I excise taxes, freeing billions for reinvestment. Financial Disclaimer: This article
cannabis
AI-driven extraction raises product costs by roughly 18 percent while delivering only modest gains in potency, so the promised cannabis benefits often become pricier for patients. Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making health
cannabis
Financial Disclaimer: This article is for educational purposes only and does not constitute financial advice. Consult a licensed financial advisor before making investment decisions. The Tax Landscape: Why Execs Are Moving Fast Three tax-saving strategies have emerged as cannabis firms chase the looming FDA rule change. Executives are racing to
cannabis
Cannabis Benefits Unlocked vs NSAIDs Runners See Faster Recovery Over 60% of elite athletes report faster recovery when they incorporate CBD oil into their routine, and yes, research confirms that CBD can accelerate muscle repair more effectively than traditional NSAIDs. Clinical trials in 2023 showed a 47% faster reduction in